Martin Mynarek
Overview
Explore the profile of Martin Mynarek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stock A, Krumma J, Fleischhack G, Tippelt S, Rink L, Pietsch T, et al.
Neuroradiology
. 2025 Feb;
PMID: 39960531
Purpose: Currently, the different types of ependymal neoplasm (EPN) are defined by anatomical localization and genetics. This retrospective multicenter study aimed to analyze the imaging patterns of both local and...
2.
Okonechnikov K, Ghasemi D, Schrimpf D, Tonn S, Mynarek M, Koster J, et al.
Acta Neuropathol Commun
. 2025 Jan;
13(1):4.
PMID: 39762990
Recent genomic studies have allowed the subdivision of intracranial ependymomas into molecularly distinct groups with highly specific clinical features and outcomes. The majority of supratentorial ependymomas (ST-EPN) harbor ZFTA-RELA fusions...
3.
Engertsberger L, Benesch M, Mynarek M, Tonn S, Obrecht-Sturm D, Perwein T, et al.
Neurooncol Adv
. 2024 Dec;
6(1):vdae179.
PMID: 39713042
Background: Ependymomas of the spinal cord are rare among children and adolescents, and the individual risk of disease progression is difficult to predict. This study aims to evaluate the prognostic...
4.
Obrecht-Sturm D, Schoof M, Eckhardt A, Mynarek M, Gilbert M, Aldape K, et al.
Neuro Oncol
. 2024 Aug;
27(1):267-276.
PMID: 39171767
Background: Ependymoma (EPN) is not a uniform disease but represents different disease types with biological and clinical heterogeneity. However, the pattern of when and where different types of EPN relapse...
5.
Liu A, Li B, Vasiljevic A, Dewan M, Tamrazi B, Ertl-Wagner B, et al.
Neuro Oncol
. 2024 Jul;
26(12):2159-2173.
PMID: 39073785
Pineal parenchymal tumors are rare neoplasms for which evidence-based treatment recommendations are lacking. These tumors vary in biology, clinical characteristics, and prognosis, requiring treatment that ranges from surgical resection alone...
6.
Godbole S, Voss H, Gocke A, Schlumbohm S, Schumann Y, Peng B, et al.
Nat Commun
. 2024 Jul;
15(1):6237.
PMID: 39043693
Medulloblastomas (MBs) are malignant pediatric brain tumors that are molecularly and clinically heterogenous. The application of omics technologies-mainly studying nucleic acids-has significantly improved MB classification and stratification, but treatment options...
7.
Sonksen M, Obrecht-Sturm D, Hernaiz Driever P, Sauerbrey A, Graf N, Kontny U, et al.
Neuro Oncol
. 2024 Jun;
26(11):2125-2139.
PMID: 38919026
Background: The outcome of children with medulloblastoma (MB) and Fanconi Anemia (FA), an inherited DNA repair deficiency, has not been described systematically. Treatment is complicated by high vulnerability to treatment-associated...
8.
Adolph J, Fleischhack G, Tschirner S, Rink L, Dittes C, Mikasch R, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893076
Background: Radiotherapy (RT) involving craniospinal irradiation (CSI) is important in the initial treatment of medulloblastoma. At recurrence, the re-irradiation options are limited and associated with severe side-effects. Methods: For pre-irradiated...
9.
Mynarek M, Rossius A, Guiard A, Ottensmeier H, von Hoff K, Obrecht-Sturm D, et al.
Neuro Oncol
. 2024 Jun;
26(11):2113-2124.
PMID: 38835160
Background: Neurocognition can be severely affected in pediatric brain tumor survivors. We analyzed the association of cognitive functioning with radiotherapy dose, postoperative cerebellar mutism syndrome (pCMS), hydrocephalus, intraventricular methotrexate (MTX)...
10.
Obrecht-Sturm D, Schomig L, Mynarek M, Bison B, Schwarz R, Pietsch T, et al.
Neuro Oncol
. 2024 Apr;
26(9):1712-1722.
PMID: 38578306
Background: This study aims at clarifying the impact of persistent residual lesions following first-line treatment for pediatric medulloblastoma. Methods: Data on 84 pediatric patients with medulloblastoma and persistent residual lesions...